CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors
暂无分享,去创建一个
E. Bowman | J. Freudenheim | P. Shields | J. Vena | C. Ambrosone | K. Moysich | H. Furberg | S. Graham | Sabrina Ahmed
[1] J. Parry,et al. The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis. , 2002, Mutagenesis.
[2] J. Martens,et al. NF-1C, Sp1, and Sp3 are essential for transcription of the human gene for P450c17 (steroid 17alpha-hydroxylase/17,20 lyase) in human adrenal NCI-H295A cells. , 2001, Molecular endocrinology.
[3] S. Narod,et al. Re: CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. , 2001, Journal of the National Cancer Institute.
[4] G. Coetzee,et al. Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates. , 2001, Cancer research.
[5] V. Kosma,et al. Steroid metabolism gene CYP17 polymorphism and the development of breast cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[6] Y. Miyoshi,et al. Genetic polymorphism in CYP17 and breast cancer risk in Japanese women. , 2000, European journal of cancer.
[7] G. Giles,et al. CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. , 2000, Journal of the National Cancer Institute.
[8] K. Matsuo,et al. No Association of the 5′Promoter Region Polymorphism of CYP17 with Breast Cancer Risk in Japan , 2000, Japanese journal of cancer research : Gann.
[9] E. Imyanitov,et al. CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women. , 2000, Cancer letters.
[10] B. Ponder,et al. A Systematic Review Of Genetic Polymorphisms and Breast Cancer Risk 1 , 2000 .
[11] Chen-Yang Shen,et al. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. , 1999, Cancer research.
[12] M. Gentile,et al. Association between CYP17 gene polymorphism and risk of breast cancer in young women , 1999, International journal of cancer.
[13] M. Pike,et al. Cytochrome P450c17α Gene (CYP17) Polymorphism Predicts Use of Hormone Replacement Therapy , 1999 .
[14] P. Lønning,et al. CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1. , 1999, Cancer research.
[15] W. Willett,et al. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. , 1999, Cancer research.
[16] I. Bleiweiss,et al. CYP17 genotype and breast cancer risk. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[17] D. Bell,et al. Association between CYP17 polymorphisms and the development of breast cancer. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[18] D. Eckerman. Human Variability in Response to Chemical Exposures Measures, Modeling, and Risk Assessment , 1998 .
[19] B. Ponder,et al. No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer. , 1998, British Journal of Cancer.
[20] M. Pike,et al. Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. , 1998, Cancer research.
[21] B. Henderson,et al. A polymorphism in intron 6 of the CYP17 gene , 1997, Clinical genetics.
[22] G. Coetzee,et al. A polymorphism in the CYP17 gene increases the risk of breast cancer. , 1997, Cancer research.
[23] J. Freudenheim,et al. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. , 1996, JAMA.
[24] J. Freudenheim,et al. Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. , 1996, Journal of the National Cancer Institute.
[25] K. Morohashi,et al. Gene regulation of steroidogenesis , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[26] J. Little,et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. , 1994, Human molecular genetics.
[27] L. Hayman,et al. Correspondence , 1992, Neuroradiology.
[28] J. Freudenheim,et al. Nutritional epidemiology of postmenopausal breast cancer in western New York. , 1991, American journal of epidemiology.